The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits β-cell apoptosis in vitro

Biochemical and Biophysical Research Communications

Volumn 330, Issue 2, 2005, Pages 577-584

  Bregenholt, Søren ^a   Møldrup, Annette ^a   Blume, Niels ^a   Karlsen, Allan E ^b   Friedrichsen, Birgitte Nissen ^a   Tornhave, Ditte ^a   Knudsen, Lotte Bjerre ^a   Petersen, Jacob S ^a  

^a NOVO NORDISK A S   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

Apoptosis; Cytokines; Free fatty acids; GLP 1; Liraglutide; cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADENYLATE CYCLASE ACTIVATOR; CYCLIC AMP; CYTOKINE; EXENDIN 4; FATTY ACID; FORSKOLIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; LIRAGLUTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; IN VITRO STUDY; INTERMETHOD COMPARISON; MOLECULAR INTERACTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 15744381238     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.013     Document Type: Article

References (45)

1. D. Mauricio, and T. Mandrup-Poulsen Apoptosis and the pathogenesis of IDDM. A question of life and death Diabetes 47 1998 1537 1543
2. T. Mandrup-Poulsen Beta-cell apoptosis: stimuli and signaling Diabetes 50 2001 58 63
3. M. Shimabukuro, Y.-T. Zhou, M. Levi, and R.H. Unger Fatty acid-induced β-cell apoptosis: a link between obesity and diabetes Proc. Natl. Acad. Sci. USA 95 1998 2498 2502
4. K. Maedler, G.A. Spinas, D. Dyntar, W. Moritz, N. Kaiser, and M.Y. Donath Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function Diabetes 50 2001 69 76
5. R.H. Unger, and L. Orci Diseases of liporegulation: new perspective on obesity and related disorders FASEB J. 15 2001 312 321
6. A.M.J. Shapiro, J.R.T. Lakey, E.A. Ryan, G.S. Korbutt, E. Toth, G.L. Warnock, N.M. Kneteman, and R.V. Rajotte Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen N. Engl. J. Med. 343 2000 230 238
7. J.J. Holst Enteroglucagon Annu. Rev. Physiol. 59 1997 257 271
8. D.J. Drucker The glucagon-like peptides Endocrinology 142 2001 521 527
9. R. Perfetti, and P. Merkel Glucagon-like peptide-1: a major regulator of pancreatic β-cell function Eur. J. Endocrinol. 143 2000 717 725
10. J.H. Nielsen, E.D. Galsgaard, A. Moldrup, B. Nissen Freidrichsen, N. Billestrup, J.A. Hansen, Y.C. Lee, and C. Carlson Regulation of β-cell mass by hormones and growth factors Diabetes 50 2001 25 29
11. N. Ishizuka, K. Yagui, Y. Tokuyama, K. Yamada, Y. Suzuki, J. Miyazaki, N. Hashimoto, H. Makino, Y. Saito, and A. Kanatsuka Tumor necrosis alpha signaling pathway and apoptosis in pancreatic beta cells Metabolism 48 1999 1485 1492
12. R. Perfetti, J. Zhou, M.E. Doyle, and J.M. Egan Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homebox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats Endocrinology 141 2000 4600 4605
13. J. Buteau, R. Roduit, S. Susini, and M. Prentki Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homebox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells Diabetologia 42 1999 856 864
14. G. Xu, D.A. Stoffers, J.F. Habener, and S. Bonner-Wier Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats Diabetes 48 1999 2270 2276
15. H. Hui, C. Wright, and R. Perfetti Glugagon-like peptide 1 induces differentiation of islet duodenal homebox-1-positive pancreatic ductal cells into insulin-secreting cells Diabetes 50 2001 785 796
16. C. Tourrel, D. Bailbé, M.-J. Meile, M. Kergoat, and B. Portha Glucagon-Like peptide-1 and exendine-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age Diabetes 50 2001 1562 1570
17. A.I. Urusova, L. Farilla, H. Hui, E. D'Amico, and R. Perfetti GLP-1 inhibition of pancreatic islet cell apoptosis Trends Endocrinol. Metab. 15 2004 27 33
18. H. Hui Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cell via a cyclic 5′-adenosine monophosphate-dependent protein kinase A and a phosphatidylinositol 3-kinase-dependent pathway Endocrinology 144 2003 1444 1455
19. G. Kwon, K.L. Pappan, C.A. Marshall, J.E. Schaffer, and M.L. McDaniel cAMP dose-dependently prevents palmitate-induced apoptosis by both protein kinase A and cAMP-guanine nucleotide exchange factor-dependent pathways in beta-cells J. Biol. Chem. 279 2004 8938 8945
20. L. Farilla, A. Bulotta, B. Hirshberg, S.L. Calzi, N. Khoury, H. Noushmerhr, C. Bertolotto, U.D. Mario, D.M. Harlan, and R. Perfetti Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets Endocrinology 144 2003 5149 5158
21. Y. Li, T. hansotia, B. Yusta, F. Ris, P.A. Halban, and D.J. Drucker Glucagon-like peptide 1 receptor signalling modulates beta cell apoptosis J. Biol. Chem. 278 2003 471 478
22. L. Farilla, H. Hui, C. Bertolotto, E. Kang, A. Bulotta, U.D. Mario, and R. Perfetti Glucagon-like peptide 1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats Endocrinology 143 2002 4397 4408
23. L.B. Knudsen, P.F. Nielsen, P.O. Huusfeldt, N.L. Johansen, K. Madsen, F.Z. Pedersen, H. Thøgersen, M. Wilken, and H. Agsersø Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration J. Med. Chem. 43 2000 1664 1669
24. L. Bjerre Knudsen, H. Agsersø, C. Bjenning, S. Bregenholt, R.D. Carr, C. Godtfredsen, J.J. Holst, P.O. Huusfeldt, M.O. Larsen, P.J. Larsen, P.F. Nielsen, U. Ribel, B. Rolin, J. Romer, J. Sturis, M. Wilken, and P. Kristensen GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes Drugs Future 26 2001 677 685
25. K.B. Degn, C.B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B.R. Landau, and O. Schmitz One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes Diabetes 53 2004 1187 1194
26. C.B. Juhl, M. Hollingdal, N. Pørksen, J. Sturis, G. Jakobsen, and O. Schmitz Evidence of a substantial reduction in fasting and post prandial glycemia i type 2 diabetes after bedtime administration of a long-acting GLP-1 derivative, NN2211 Diabetes 50 2001 2
27. S. Bregenholt, M. Röpke, S. Skov, and M.H. Claesson Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions J. Immunol. 157 1996 993 999
28. lck tyrosine kinase, leads to an alternative phenotype of the TCR/CD3 ζ-chain, and induces apoptosis J. Immunol. 158 1997 3189 3196
29. R. Lupi, F. Dotta, L. Marselli, S. Del Guerra, M. Masini, C. Santangelo, G. Patané, U. Boggi, S. Piro, M. Anello, E. Bergamini, F. Mosca, U. Di Mario, S. Del Prato, and P. Marchetti Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated Diabetes 51 2002 1437 1442
30. S. Piro, M. Anello, C. Di Pietro, M.N. Lizzio, G. Patanè, A.M. Rabuazzo, R. Vigneri, M. Purrello, and F. Purrello Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress Metabolism 51 2002 1340 1347
31. I. Kharroubi, L. Ladrière, A.K. Cardozo, Z. Dogusan, M. Cnop, and D.L. Eizirik Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress Endocrinology 145 2004 5087 5096
32. A.K. Azevedo-Martins, S. Lortz, S. Lenzen, R. Curi, D.L. Eizirik, and M. Tiedge Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells Diabetes 52 2003 93 101
33. C. Montrose-Rafizadeh, P. Avdonin, M.J. Garant, B.D. Rodgers, S. Kole, H. Yang, H.M.A. Levine, W. Schwindinger, and M. Bernier Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in chinese hamster ovary cells Endocrinology 140 1999 1132 1140
34. M. Shimabukuro, M.-Y. Wang, Y.-T. Zhou, C.B. Newgard, and R.H. Unger Protection against lipoapoptosis of βετα cells through leptin-dependent maintenance of Bcl-2 expression Proc. Natl. Acad. Sci. USA 95 1998 9558 9561
35. D.J. Hill, J. Petrik, E. Arany, T.J. McDonald, and T.L. Delovitch Insulin-like growth factors prevent cytokine-mediated cell death in isolated islets of Langerhans from pre-diabetic non-obese diabetic mice J. Endocrinol. 161 1999 153 162
36. D.J. Burks, and M.F. White IRS proteins and beta-cell function Diabetes 50 2001 S140 S145
37. K. Trumper, A. Trumper, H. Trusheim, R. Arnold, B. Goke, and D. Horsch Integrative mitogenic role of protein kinase B/Akt in beta-cells Ann. NY Acad. Sci. 921 2000 242 250
38. i and a wortmannin-sensitive signalling pathway Biochem. Biophys. Res. Commun. 224 1996 369 374
39. J.S. Richards New signaling pathways for hormones and cyclic adenosin 3′-5′-monophosphate action in endocrine cells Mol. Endocrinol. 15 2001 209 218
40. B. Yusta, R.P. Boushey, and D.J. Drucker The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway J. Biol. Chem. 275 2000 35345 35352
41. P.R. Webb, K.Q. Wang, D. Scheel-Toellner, J. Pongracz, M. Salmon, and J.M. Lord Regulation of neutrophil apoptosis: a role for protein kinase C and phosphatidylinositol-3-kinase Apoptosis 5 2001 451 458
42. T.G. Cross, D. Scheel-Toellner, N.V. Henriquez, E. Deacon, M. Salmon, and J.M. Lord Serine/threonine protein kinases and apoptosis Exp. Cell Res. 256 2000 34 41
43. F. Hong, V.A. Nguyen, X. Shen, G. Kunos, and B. Gao Rapid activation of protein kinase B/Akt has a key role in antiapoptotic signaling during liver regeneration Biochem. Biophys. Res. Commun. 279 2000 974 979
44. K.S. Cho, J.H. Lee, S. Kim, D. Kim, H. Koh, J. Lee, C. Kim, J. Kim, and J. Chung Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3-kinase-dependent signaling pathway Proc. Natl. Acad. Sci. USA 98 2001 6144 6149
45. A. Strasser, L. O'Connor, and V.M. Dixit Apoptosis signaling Annu. Rev. Biochem. 69 2000 217 245